标题
Access to biologicals in Crohn’s disease in ten European countries
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 34, Pages 6294
出版商
Baishideng Publishing Group Inc.
发表日期
2017-09-14
DOI
10.3748/wjg.v23.i34.6294
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014
- (2016) J. Kirchgesner et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Patients’ access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences
- (2016) László Gulácsi et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis
- (2016) Paweł Moćko et al. Pharmacological Reports
- The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
- (2015) Ashok Jha et al. ADVANCES IN THERAPY
- Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists
- (2015) Petra Baji et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Biological therapy in inflammatory bowel diseases: Access in Central and Eastern Europe
- (2015) Fanni Rencz WORLD JOURNAL OF GASTROENTEROLOGY
- A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia
- (2015) Valentin Brodszky et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?
- (2013) Polina Putrik et al. ANNALS OF THE RHEUMATIC DISEASES
- Inequities in access to biologic and synthetic DMARDs across 46 European countries
- (2013) Polina Putrik et al. ANNALS OF THE RHEUMATIC DISEASES
- Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013)
- (2013) José Luis Cabriada et al. Gastroenterologia y Hepatologia
- The burden of inflammatory bowel disease in Europe
- (2013) Johan Burisch et al. Journal of Crohns & Colitis
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries
- (2011) Joëlle M. Hoebert et al. HEALTH POLICY
- Need for standardization in population-based quality of life studies
- (2009) Marte Lie Hoivik et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now